Getty ImagesAnand Rathi has buy call on with a target price of Rs 475. The current market price of Jubilant Pharmova is Rs 418.25. Anand Rathi recommended to keep stop loss at Rs 365.
Jubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceuticals sector.
Jubilant Pharmova key Products/Revenue Segments include Organic Chemicals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 1612.60 Crore, up 10.22 % from last quarter Total Income of Rs 1463.03 Crore and down -2.97 % from last year same quarter Total Income of Rs 1661.90 Crore. Company has reported net profit after tax of Rs 7.58 Crore in latest quarter.
The company’s top management includes Mr.Shyam S Bhartia, Dr.Ashok Misra, Ms.Sudha Pillai, Mr.Sushil Kumar Roongta, Mr.Vivek Mehra, Mr.Arjun Shanker Bhartia, Mr.Priyavrat Bhartia, Mr.Arun Seth, Mr.Arvind Chokhany, Mr.R Kumar, Mr.Hari S Bhartia, Mr.S Sridhar. Company has B S R & Co. LLP as its auditors. As on 30-09-2022, the company has a total of 16 Crore shares outstanding.
Investment Rationale
The stock has confirmed a range breakout above 404 mark. The price action in the stock is accompanied with rise in volumes which suggests a genuine breakout. The stock has also managed to sustain above its 200 DMA which suggests change of trend.
Promoter/FII Holdings
Promoters held 50.68 per cent stake in the company as of 30-Sep-2022, while FIIs owned 23.47 per cent, DIIs 1.6 per cent.
Jubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceuticals sector.
Jubilant Pharmova key Products/Revenue Segments include Organic Chemicals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 1612.60 Crore, up 10.22 % from last quarter Total Income of Rs 1463.03 Crore and down -2.97 % from last year same quarter Total Income of Rs 1661.90 Crore. Company has reported net profit after tax of Rs 7.58 Crore in latest quarter.
The company’s top management includes Mr.Shyam S Bhartia, Dr.Ashok Misra, Ms.Sudha Pillai, Mr.Sushil Kumar Roongta, Mr.Vivek Mehra, Mr.Arjun Shanker Bhartia, Mr.Priyavrat Bhartia, Mr.Arun Seth, Mr.Arvind Chokhany, Mr.R Kumar, Mr.Hari S Bhartia, Mr.S Sridhar. Company has B S R & Co. LLP as its auditors. As on 30-09-2022, the company has a total of 16 Crore shares outstanding.
Investment Rationale
The stock has confirmed a range breakout above 404 mark. The price action in the stock is accompanied with rise in volumes which suggests a genuine breakout. The stock has also managed to sustain above its 200 DMA which suggests change of trend.
Promoter/FII Holdings
Promoters held 50.68 per cent stake in the company as of 30-Sep-2022, while FIIs owned 23.47 per cent, DIIs 1.6 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.